Repligen (RGEN) Cash from Investing Activities (2010 - 2026)
Repligen (RGEN) posted quarterly Cash from Investing Activities of -$2.1 million for Q2 2026, up 73.35% year-over-year from -$1.2 million in Q2 2025, and up 47.62% quarter-over-quarter from -$4.0 million in Q1 2026.
Repligen (RGEN) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Cash from Investing Activities for 17 consecutive years, with -$2.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 73.35% year-over-year to -$2.1 million; the TTM figure through Jun 2026 stood at -$222.6 million (down 45.9% YoY), while the FY2025 annual figure was -$298.5 million, down 245.52% from the prior year.
- Cash from Investing Activities improved to -$2.1 million in Q2 2026 per RGEN's latest filing, from -$4.0 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $64.8 million in Q2 2023 and bottomed at -$208.7 million in Q4 2025.
- Historically, Cash from Investing Activities has averaged -$41.5 million across 5 years, with a median of -$9.1 million in 2023.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities surged 347.27% — and 2025, when it sank 786.25%.
- Repligen's Cash from Investing Activities stood at -$121.3 million in 2022, then slumped by 40.06% to -$169.9 million in 2023, then surged by 61.88% to -$64.8 million in 2024, then sank by 222.32% to -$208.7 million in 2025, then surged by 99.0% to -$2.1 million in 2026.
- Business Quant data shows RGEN's Cash from Investing Activities at -$2.1 million in Q2 2026, -$4.0 million in Q1 2026, and -$208.7 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -26.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -241.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -222.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -383.65 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -461.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -87.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -90.00 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -117.00 Mn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | -2.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.09 Mn |
| Jun 30, 2026 | -2.09 Mn |
| Mar 31, 2026 | -3.99 Mn |
| Mar 31, 2026 | -3.99 Mn |
| Dec 31, 2025 | -208.74 Mn |
| Dec 31, 2025 | -208.74 Mn |
| Sep 30, 2025 | -7.78 Mn |
| Sep 30, 2025 | -7.78 Mn |
| Jun 30, 2025 | -7.84 Mn |
| Jun 30, 2025 | -7.84 Mn |
| Mar 31, 2025 | -74.11 Mn |
| Mar 31, 2025 | -74.11 Mn |
| Dec 31, 2024 | -64.76 Mn |
| Dec 31, 2024 | -64.76 Mn |
| Sep 30, 2024 | -5.86 Mn |
| Sep 30, 2024 | -5.86 Mn |
| Jun 30, 2024 | -7.40 Mn |
| Jun 30, 2024 | -7.40 Mn |
| Mar 31, 2024 | -8.36 Mn |
| Mar 31, 2024 | -8.36 Mn |